第1个回答 2011-10-11
Using Sanger dideoxy chain termination method using T7 Sequencing TM Kit according to the instructions. [N a P]
dATP labeled. 8% polyacrylamide gel, the thickness of 0.4mm, plastic long 55cm, electrophoresis in Pharmach LKB's Macrophor sequencer on, 1200V ~ 1500V, 2 ~ 5 hours. Sequencing product set x
Negative light exposing, in a 20 ℃ overnight autoradiography.
AT PJtts Cloning and expression of the solid base pPGAP-AT with the NcoI-SalI double digestion, insert pBV220, the AT received pBV220 a a1 a plasmid. Then one of a1-AT (BamHl-Ava1) after site-directed mutagenesis with PCR fragments of mutated fragments (BamHI-AvaI) replacement, that is to be barrier-based purpose pBV220 AT P [tts expression plasmid. That
Plasmid was transformed into E. coli HB101, in LB medium 30 "C to the logarithmic growth of the mid-.42" C-induced 3 hours. Collection of biomass, respectively, after sonication with 1mol / L, 2mol / L urea washing, 8mol / L urea solution
Inclusion bodies.
第2个回答 2011-10-13
采用Sanger双脱氧链末端终止法,按T7 Sequencing TM Kit使用说明操作。[n一 P]
Using Sanger dideoxy chain termination method, according to the T7 Sequencing TM Kit usage instructions. [ n P]
dATP标记。8% 变性聚丙烯酰胺凝胶,厚度0.4mm,胶长55cm,电泳在Pharmach LKB公司的Macrophor测序仪上进行,1200V~1500V,2~5小时。测序产物置x
DATP markers. 8% denaturing polyacrylamide gel, gel thickness 0.4mm, long 55cm, electrophoresis in Pharmach LKB's Macrophor sequencing instrument, 1200V ~ 1500V, 2 ~ 5 hours. The sequencing of the X product
光负片爆光,于一20℃过夜,放射自显影。
Light negative exposure, in a 20 degrees overnight, autoradiography.
AT PJtts基固克隆与表达 将pPGAP —AT用NcoI—SalI双酶切,插入pBV220中,得到pBV220一a1一AT重组质粒。再将其中的a1-AT(BamHl—Ava1)片段用PCR定点诱变后的突变片段(BamHI—AvaI)置换,即得到垒基目的pBV220 AT P[tts表达质粒。该
AT PJtts based solid cloning and expression of pPGAP - AT NcoI - SalI double digestion, insert pBV220, pBV220 A1 AT recombinant plasmid. And then one of the a1-AT ( BamHl - Ava1 ) fragment with PCR site-directed mutagenesis of the mutant fragment ( BamHI - AvaI ) replacement, namely base base to pBV220 AT P [ TTS expression plasmid. The
质粒转化大肠杆菌HB101,在LB培养基中30"C生长至对数中期.42"C诱导3小时。收集菌体,超声破碎后分别用1mol/L,2mol/L尿素洗涤,8mol/L尿素溶解
Plasmid was transformed into E. coli HB101, in LB medium 30" C growth to the logarithmic term . 42" C induced by 3 hours. Lactobacillus collection, ultrasonic crushing respectively after using 1mol / L, 2mol / L urea washing, 8mol / L dissolving urea
包涵体。
Inclusion body.
第3个回答 2011-10-11
The Sanger double deoxidizing chain end, according to terminate method T7 Sequencing TM Kit instructions operation. [n a P]
DATP mark. 8% degeneration polyacrylamide gel, thickness of 0.4 mm, 55 cm long, electrophoresis glue in Pharmach LKB company Macrophor sequencing instrument, 1200 V ~ 1500 V, 2 ~ 5 hours. Sequencing product for x
The light of the negative light, in a critical 20 ℃ for the night, radiation from enhancement.
AT PJtts base solid cloning and expression will pPGAP-AT NcoI-SalI with double enzyme, insert pBV220 cut, get pBV220 a a1 AT a restructuring plasmid. Then one of the a1-AT (BamHl-Ava1) clips with the mutation PCR site-directed mutagenesis footage (BamHI-AvaI), that is, get base and replacement pBV220 purpose AT P [TTS expression plasmid. This
Plasmid into e. coli HB101, the medium in langmuir-blodgett 30 "C growth to mid logarithm. 42" C induction of three hours. Collect bacteria, ultrasonic broken respectively with 1 mol/after L, 2 mol/L urea washing, 8 mol/L urea dissolve
Inclusion body
第4个回答 2011-10-11
翻译
The Sanger double deoxidizing chain end, according to terminate method T7 Sequencing TM Kit instructions operation. [n a P]
DATP mark. 8% degeneration polyacrylamide gel, thickness of 0.4 mm, 55 cm long, electrophoresis glue in Pharmach LKB company Macrophor sequencing instrument, 1200 V ~ 1500 V, 2 ~ 5 hours. Sequencing product for x
The light of the negative light, in a critical 20 ℃ for the night, radiation from enhancement.
AT PJtts base solid cloning and expression will pPGAP-AT NcoI-SalI with double enzyme, insert pBV220 cut, get pBV220 a a1 AT a restructuring plasmid. Then one of the a1-AT (BamHl-Ava1) clips with the mutation PCR site-directed mutagenesis footage (BamHI-AvaI), that is, get base and replacement pBV220 purpose AT P [TTS expression plasmid. This
Plasmid into e. coli HB101, the medium in langmuir-blodgett 30 "C growth to mid logarithm. 42" C induction of three hours. Collect bacteria, ultrasonic broken respectively with 1 mol/after L, 2 mol/L urea washing, 8 mol/L urea dissolve
Inclusion body.
第5个回答 2011-10-11
Using Sanger dideoxy chain termination method, according to the T7 Sequencing TM Kit usage instructions. [ n P]DATP markers. 8% denaturing polyacrylamide gel, gel thickness 0.4mm, long 55cm, electrophoresis in Pharmach LKB's Macrophor sequencing instrument, 1200V ~ 1500V, 2 ~ 5 hours. The sequencing of the X productLight negative exposure, in a 20 degrees overnight, autoradiography.AT PJtts based solid cloning and expression of pPGAP - AT NcoI - SalI double digestion, insert pBV220, pBV220 A1 AT recombinant plasmid. And then one of the a1-AT ( BamHl - Ava1 ) fragment with PCR site-directed mutagenesis of the mutant fragment ( BamHI - AvaI ) replacement, namely base base to pBV220 AT P [ TTS expression plasmid. ThePlasmid was transformed into E. coli HB101, in LB medium 30" C growth to the logarithmic term . 42" C induced by 3 hours. Lactobacillus collection, ultrasonic crushing respectively after using 1mol / L, 2mol / L urea washing, 8mol / L dissolving ureaInclusion body.